Attached files
| file | filename |
|---|---|
| EX-32.2 - EX-32.2 - MyoKardia, Inc. | myok-ex322_12.htm |
| EX-32.1 - EX-32.1 - MyoKardia, Inc. | myok-ex321_8.htm |
| EX-31.2 - EX-31.2 - MyoKardia, Inc. | myok-ex312_7.htm |
| EX-31.1 - EX-31.1 - MyoKardia, Inc. | myok-ex311_9.htm |
| EX-21.1 - EX-21.1 - MyoKardia, Inc. | myok-ex211_1296.htm |
| EX-4.2 - EX-4.2 - MyoKardia, Inc. | myok-ex42_1297.htm |
| 10-K - 10-K - MyoKardia, Inc. | myok-10k_20191231.htm |
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We hereby consent to the incorporation by reference in the Registration Statements on Forms S-3 (Nos. 333-223526 and 333-219220) and Forms S-8 (Nos. 333-229699, 333-222866, 333-215822, and 333-207674) of MyoKardia, Inc. of our report dated February 27, 2020 relating to the financial statements and the effectiveness of internal control over financial reporting, which appears in this Form 10-K.
PricewaterhouseCoopers LLP
San Jose, California
February 27, 2020